TW200716160A - Gastrointestinal composition - Google Patents

Gastrointestinal composition

Info

Publication number
TW200716160A
TW200716160A TW095116012A TW95116012A TW200716160A TW 200716160 A TW200716160 A TW 200716160A TW 095116012 A TW095116012 A TW 095116012A TW 95116012 A TW95116012 A TW 95116012A TW 200716160 A TW200716160 A TW 200716160A
Authority
TW
Taiwan
Prior art keywords
composition
feeling
gastrointestinal
gastrointestinal composition
atractylodes
Prior art date
Application number
TW095116012A
Other languages
Chinese (zh)
Other versions
TWI430807B (en
Inventor
Tomohiko Nakata
Ryou Kanaya
Norikazu Yamaguchi
Akiyoshi Oohira
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Publication of TW200716160A publication Critical patent/TW200716160A/en
Application granted granted Critical
Publication of TWI430807B publication Critical patent/TWI430807B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284—Atractylodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Nutrition Science (AREA)
  • Otolaryngology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention is to provide a gastrointestinal composition, of which the therapeutic effect is remarkably enhanced. This composition comprising Vitamin U and Atractylodes lancea De Candolle or Atractylodes chinensis Koidzumi is particularly used for inhibiting a feeling of belch, nausea, vomiting and for reducing a feeling of breast obstruction, stomach oppression, indigestion, gastric distension or inappetence.
TW095116012A 2005-05-30 2006-05-05 Gastrointestinal composition for synergistically increasing peristalsis of digestive tract TWI430807B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005156667 2005-05-30
PCT/JP2006/309791 WO2006129479A1 (en) 2005-05-30 2006-05-17 Gastrointestinal drug composition

Publications (2)

Publication Number Publication Date
TW200716160A true TW200716160A (en) 2007-05-01
TWI430807B TWI430807B (en) 2014-03-21

Family

ID=37481410

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095116012A TWI430807B (en) 2005-05-30 2006-05-05 Gastrointestinal composition for synergistically increasing peristalsis of digestive tract

Country Status (5)

Country Link
JP (1) JP5070047B2 (en)
KR (1) KR101254511B1 (en)
CN (1) CN101141972A (en)
TW (1) TWI430807B (en)
WO (1) WO2006129479A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010250196A1 (en) * 2009-05-22 2012-01-19 Sk Chemicals Co., Ltd. Composition for preventing or treating irritable bowel syndrome
KR20130066874A (en) * 2011-12-13 2013-06-21 에스케이케미칼주식회사 Compound for preventing or treating irritable bowel syndrome and composition containing the same

Also Published As

Publication number Publication date
JP5070047B2 (en) 2012-11-07
WO2006129479A1 (en) 2006-12-07
JPWO2006129479A1 (en) 2008-12-25
KR101254511B1 (en) 2013-04-19
KR20080026084A (en) 2008-03-24
CN101141972A (en) 2008-03-12
TWI430807B (en) 2014-03-21

Similar Documents

Publication Publication Date Title
MX2010003651A (en) Lipid compositions for the treatment of gastro-intestinal disorders and the promotion of intestinal development and maturation.
EP2043679A4 (en) Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
EP2061503A4 (en) Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
MX2010004486A (en) Pressure sensing intragastric balloon.
EP1855581A4 (en) Tethered capsule endoscope for barrett's esophagus screening
MX2009005004A (en) Coreotics.
IL186230A0 (en) Anticancer combination therapy using sunitinib malate
EP1689412A4 (en) Vitamin d analogs for obesity prevention and treatment
IL200090A0 (en) Composition for treatment of undifferentiated-type of gastric cancer
BRPI0511502A (en) Gastric bypass band and surgical method
UA95464C2 (en) Pyridopyrazine derivatives and use thereof
AU2003219211A1 (en) Gastric ring for the treatment of obesity
MY158325A (en) Multitype peptide compositions and methods for treatment or prevention of human papillpmavirus infection
GB0502985D0 (en) Therapeutic uses of tomato extracts
IL188847A0 (en) Nutrition for obese patients
PT2173196E (en) Use of probiotics and fibers for diarrhoea
GB0610790D0 (en) Therapeutic uses of tomato extracts
WO2008046865A3 (en) Long-term feed - elderly
IL198912A0 (en) Isosorbide mononitrate derivatives for the treatment of intestinal disorders
MX2009011822A (en) Hydroxy sulfonate of quinone compounds and their uses.
TW200716160A (en) Gastrointestinal composition
WO2006046871A3 (en) Peri-operative composition comprising lactobacillus rhamnosus
WO2009142428A3 (en) Pharmaceutical composition for the treatment of premature ejaculation
WO2008073311A3 (en) Substituted diazepine sulfonamides as bombesin receptor subtype-3 modulators
WO2011042501A3 (en) Glp-2 for use in intestine and muscle recovery